Read the article about Novolin 70 30, a medication used to control diabetes. Know its benefits, doses and possible side effects.

Novolin 70/30 is a medication that is usually prescribed to people with diabetes. It is a combination of two types of insulin: 70% of NPH, also known as insulin making neutral protamine, and 30% normal insulin. This unique formulation provides a short and intermediate action insulin balance to help control blood sugar levels.

Novolin 70/30 is mainly used in people with type 2 diabetes that require insulin treatment to control their blood sugar levels. It is important to keep in mind that this medicine should be used together with a healthy diet and a regular exercise routine as part of a general diabetes control plan. Novolin 70/30 is presented in liquid form and is usually sel f-administered by subcutaneous injection.

Key points:

• Novolin 70/30 is a combination of insulin for diabetes control.
• It contains 70% NPH insulin and 30% regular insulin.
• It is mainly prescribed to people with type 2 diabetes who require insulin treatment together with lifestyle modifications.
• It is administered by subcutaneous injections.

It is essential to collaborate closely with a healthcare professional to determine the appropriate dose and frequency of Novolin 70/30 injections. The dose can vary depending on individual factors such as blood sugar levels, food patterns and physical activity levels. It is necessary to regularly control blood sugar levels to adjust the dose as necessary.

Indications and Usage

Indications:

1. Type 1 diabetes treatment: Novolin 70 30 is indicated as an adjuvant of the diet and exercise to improve glycemic control in patients with type 1 diabetes mellitus.
2. Type 2 diabetes treatment: Novolin 70 30 is indicated as an adjuvant of the diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.

The use of Novolin 70 30 in pediatric patients is not recommended.

This medicine should be used under the supervision of a healthcare professional and requires dose adjustments based on the patient’s individual response. Novolin 70 30 is usually administered subcutaneously, and the dose can vary depending on the patient’s diet, their level of physical activity and metabolic needs. Regular control of blood glucose levels is crucial to ensure effective diabetes control.

It is important to keep in mind that Novolin 70 30 should not be used during hypoglycemia episodes or if the patient has a known allergy to any of the ingredients. Patients should be educated about the signs and symptoms of hypoglycemia and how to handle it properly. Any change in medication, exercise or diet regime must be discussed with a healthcare professional to ensure optimal glucose control and general wel l-being.

Dosage and Administration:

1. Dosage:

The dose of Novolin 70 30 must be individualized according to the specific needs of the patient, his medical history and his response to treatment. It is important to start with a conservative dose and adjust it gradually as necessary to achieve desired glycemic control.

• Novolin 70 30 is usually administered subcutaneously, either in the form of multiple daily injections or by continuous insulin subcutaneous infusion using an insulin pump.
• The total daily dose of Novolin 70 30 is determined by the health professional and is expressed in insulin units.
• The dose can vary depending on factors such as body weight, diet, physical activity and joint administration of other antidiabetic medications.

2. Administration:

Proper administration techniques play an important role in maximizing the effectiveness of Novolin 70 30 and minimizing the risk of adverse effects. It is important to carefully follow the instructions provided by the health professional or manufacturer of the insulin administration device.

1. Before each injection, the vial or insulin cartridge must be visually inspected to detect any anomaly such as lumps, discoloration or precipitation.
2. The injection place should be cleaned with gauze with alcohol and let it dry before administering the medication.
3. Novolin 70 30 must be injected subcutaneously into the adipose tissue of the abdomen, thigh or upper part of the arm according to the recommended rotation places.
4. The injection should be administered at an angle of 90 degrees using a syringe, needle or insulin pen device.

“The appropriate dose and administration of Novolin 70 30 are crucial to achieve optimal glycemic control in individuals with diabetes. See your health professional for a personalized orientation.”

Side Effects of Novolin 70 30

Frequent side effects:

• Nausea
• Vomiting
• Diarrhea
• Excessive sweating
• Weight gain
• Dizziness
• Headache

Although these side effects are usually mild and manageable, it is important to monitor them and inform the doctor if they persist or get worse. In some cases, it may be necessary to adjust the dose or change to an alternative medication.

Serious side effects:

1. Allergic reactions: signs may include cutaneous eruption, itching, swelling, intense dizziness or breathing difficulty.
2. Hypoglycemia (low blood sugar level): Symptoms may include tremors, sweating, tachycardia, confusion and loss of knowledge.
3. Hyperglycemia (high level of blood sugar): Symptoms may include increase in thirst, frequent urination, breath with the smell of fruit and blurred vision.
4. Reactions at the injection site: they can include redness, swelling or itching in the place of injection.
5. Signs of liver problems: such as yellowish coloration of the skin or eyes, dark urine or persistent abdominal pain.

If you experience any of these serious side effects, it is important that you look for immediate medical attention. Your doctor can evaluate your symptoms and recommend the appropriate measures to treat them. It is also important that you follow the prescribed dose and regularly control your blood sugar levels while taking Novolin 70 30 to minimize the risk of side effects and guarantee effective diabetes control.

Severe Side Effects and When to Seek Medical Attention

Symptoms to take into account:

1. Serious allergic reactions such as difficulty breathing, hives or swelling of the face, lips, tongue or throat.
2. Sugar decline symptoms (hypoglycemia), such as confusion, dizziness, blurred vision, tachycardia, sweating or tremors.
3. Symptoms of a high level of blood sugar (hyperglycemia), as an increase in thirst, frequent urination, dried mouth, breath with smell of fruit, drowsiness or dry skin and extreme hunger.

It is important to keep in mind that these are not all possible side effects of Novolin 70/30. If you experience any unusual symptom or have doubts about your medication, contact your doctor.

When to look for medical attention:

• If you experience any of the serious allergic reactions mentioned above, seek immediate medical help.
• If you cannot control low blood sugar levels despite taking appropriate measures, see your doctor.
• In case of persistent hyperglycemia or worsening of hyperglycemia symptoms, it is advisable to contact your doctor for an additional evaluation and an adjustment of your diabetes control plan.

Precautions and Contraindications

Precautions:

• Patients with known hypersensitivity to any of the Novolin 70 30 ingredients should not use this medicine.
• Regular control of blood glucose levels is necessary during treatment with Novolin 70 30 to ensure adequate glycemic control.
• Patients with renal or liver failure may require dose adjustments or additional control of their state during the use of Novolin 70 30.
• Novolin 70 30 should be used with caution in patients with a history of no n-conscious hypoglycemia or frequent episodes of low blood sugar.

Contraindications:

1. Novolin 70 30 is contraindicated in patients with diabetic ketoacidosis. This medicine is not indicated for the treatment of this disease.
2. People with type 1 diabetes should not use Novolin 70 30, since it is not suitable for controlling blood sugar levels in this population.
3. Pregnant or breastfeeding women should consult their doctor before using Novolin 70 30, since the safety of this medicine during these periods is not well established.

In summary, health professionals should carefully evaluate the patient’s medical history and take into account the precautions and contraindications associated with Novolin 70 30 before prescribing it. Repeated monitoring of blood glucose levels and appropriate dose adjustments in certain patient populations may be necessary to optimize treatment results and minimize the risk of adverse events.

Storage and Handling

Storage

• Novolin 70/30 must be kept in refrigerator between 2 ° C and 8 ° C (36 ° F and 46 ° F).
• Avoid freezing insulin, as it can cause its degradation and loss of power.
• Do not save Novolin 70/30 near the freezer or the direct trajectory of freezer air flow.
• Always check the expiration date on the container before using insulin. The expired insulin must be discarded correctly.

Handling

1. Before use, gently roll the Novolin 70/30 vial between your palms to ensure that the suspension is mixed evenly. Do not shake vigorously, as air bubbles may form.
2. Visually inspect insulin before each use. It should appear transparent and colorless. If you see particles or discoloration, do not use and consult a healthcare professional.
3. Clean the rubber stopper of the vial with an alcohol swab before inserting the needle. This helps prevent contamination.

Note: Novolin 70/30 is available in vial and pen form. The handling instructions mentioned above are applicable to both forms of administration.

Proper storage and handling of Novolin 70/30 insulin is essential to maintain its potency and ensure its safe use. Storage guidelines must be strictly followed to avoid any damage that may occur due to improper storage conditions. Remember to inspect the insulin visually, clean the vial before use, and consult a healthcare professional if you have any concerns or questions about the integrity of the product.

LikeDislike

Author of the article

Dr.Greenblatt M.

Medical oncologist at the Robert Larner College of Medicine, MD, at the University of Vermont